Coagulation factor dysregulation in Polycystic Ovary Syndrome is an epiphenomenon of obesity.
Abu Saleh Md MoinThozhukat SathyapalanAlexandra E ButlerStephen L AtkinPublished in: Clinical endocrinology (2023)
This novel data shows that clotting system abnormalities do not contribute to the intrinsic mechanisms underlying PCOS in this non-obese non-insulin resistant population of women with PCOS matched for age and body mass index, and without evidence of underlying inflammation, but rather the clotting factor changes are an epiphenomenon coincident with obesity; therefore, increased coagulability is unlikely in these nonobese PCOS women. This article is protected by copyright. All rights reserved.